ES|EN
Skip to content
se habla de ...

San Antonio hosts the world’s largest breast cancer research meeting in December

An analysis questions the risk-based screening endorsed by the WISDOM trial

Fragmented care marks the journey of women living with and beyond breast cancer

ESMO 2026 brings the global oncology community to Madrid on 23-27 October

Education and exercise help sustain breast cancer-specific quality of life in survivors

Immune and proliferation signatures point in opposite directions in stage I TNBC

Wider access to T-DM1 and pertuzumab could avert deaths from HER2+ cancer in Brazil

Supine MRI may reduce positive margins in breast-conserving surgery

Five-fraction breast radiotherapy: good tolerability and early tumour control

Neutrophil-to-lymphocyte ratio may predict pembrolizumab response in TNBC

A 50% oestrogen-receptor cutoff defines a poorly responding HER2+ subgroup

The gut microbiota-obesity axis in breast cancer: mechanisms and opportunities

De-escalating neoadjuvant therapy in HER2-positive breast cancer: who and how?

AI combines MRI radiomics and perfusion to predict response to neoadjuvant chemotherapy

Food insecurity linked to worse survival in locally advanced breast cancer

Meridian sinew tuina reduces upper limb swelling in post-surgical lymphedema

A breast tissue-specific epigenetic clock improves age estimates in breast tissue

Online diet, walking and mindfulness support weight control after breast cancer

A topology-based approach sharpens cancer gene signatures from single-cell data

Capivasertib plus fulvestrant is not cost-effective at the current price

Oncomama
Oncomama

Papers de oncología de mama y avances de las unidades de mama en España

  • Diagnosis
  • Treatment
  • Research
  • Prevention & Screening
  • Surgery & Reconstruction
  • Breast Units
  • Meetings
  • About Oncomama
  • Atril
    • OncoHub
    • Disforia
opciones
  • Diagnosis
  • Treatment
  • Research
  • Prevention & Screening
  • Surgery & Reconstruction
  • Breast Units
  • Meetings
  • About Oncomama
  • Atril
    • OncoHub
    • Disforia
  • Meetings
  • Research

San Antonio hosts the world’s largest breast cancer research meeting in December

The San Antonio Breast Cancer Symposium brings together more than 11,000 professionals from about 100 countries on 8-11 December. Advance registration closes on 2 November....

oncomama
SABCS 2026October 13, 2026
  • Breast Units
  • Prevention & Screening

An analysis questions the risk-based screening endorsed by the WISDOM trial

oncomama
J Breast ImagingOctober 13, 2026
  • Breast Units

Fragmented care marks the journey of women living with and beyond breast cancer

oncomama
Breast Cancer ResOctober 12, 2026
  • Meetings
  • Research

ESMO 2026 brings the global oncology community to Madrid on 23-27 October

oncomama
ESMO 2026October 12, 2026
  • Research
  • Treatment

Education and exercise help sustain breast cancer-specific quality of life in survivors

oncomama
Breast CancerOctober 12, 2026
Wider access to T-DM1 and pertuzumab could avert deaths from HER2+ cancer in Brazil
BreastOctober 11, 2026
Immune and proliferation signatures point in opposite directions in stage I TNBC
Eur J CancerOctober 11, 2026
Supine MRI may reduce positive margins in breast-conserving surgery
Clin Breast CancerOctober 10, 2026
Five-fraction breast radiotherapy: good tolerability and early tumour control
Clin Breast CancerOctober 10, 2026
Neutrophil-to-lymphocyte ratio may predict pembrolizumab response in TNBC
Clin Breast CancerOctober 9, 2026
A 50% oestrogen-receptor cutoff defines a poorly responding HER2+ subgroup
Cancer MedOctober 9, 2026
Copyright © 2026 | Powered by News Magazine X
oncomama  ·  oncohub  ·  disforia
Desarrollado por dosier.es y diseñado por marta ai